  Alexandria, LA

Northshore Research Associates

Gout

ABP-745

Atom Therapeutics Co., Ltd

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subjects with acute gout. Efficacy of ABP-745 in reducing pain and swelling compared with standard colchicine treatment and placebo will be evaluated in participants with acute gout. The primary efficacy measurement will be pain score after treatment.

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Northshore Research Associates | Alexandria, LA

Site insights

Work at this site?

Active trials

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Trial sponsors